Form 8-K - Current report:
SEC Accession No. 0001193125-24-200629
Filing Date
2024-08-14
Accepted
2024-08-14 16:11:59
Documents
14
Period of Report
2024-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d838115d8k.htm   iXBRL 8-K 23596
2 EX-99.1 d838115dex991.htm EX-99.1 62458
  Complete submission text file 0001193125-24-200629.txt   219183

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tecx-20240814.xsd EX-101.SCH 2877
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tecx-20240814_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tecx-20240814_pre.xml EX-101.PRE 11279
16 EXTRACTED XBRL INSTANCE DOCUMENT d838115d8k_htm.xml XML 3639
Mailing Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 210 WATERTOWN MA 02472 (339) 666-3320
Tectonic Therapeutic, Inc. (Filer) CIK: 0001681087 (see all company filings)

EIN.: 810710585 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 241207840
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)